Research
KIT researchers offer a new perspective on N-acetylated amino acids as potential buffers in cellular energy and metabolic balance When muscles work intensively or brown adipose tissue produces heat in response to cold, metabolism shifts into high gear. Under these conditions, levels of so-called N-acetylated amino acids increase. These are chemically modified amino acids to […]
read more
A local barrier against respiratory viruses
Fraunhofer IGB News Brief / August 18, 2026 How can a respiratory virus be stopped before it spreads throughout the body? In the MucoShield project, Prime Vector Technologies, the NMI Tübingen, and Fraunhofer IGB are developing an intranasal vaccine candidate against human metapneumovirus (HMPV), which causes hundreds of thousands of cases of severe respiratory disease […]
read more
Universität Heidelberg Achieves Top Placements in Shanghai Ranking
Ruperto Carola in 59th place worldwide – among the “Top 3” in Germany Heidelberg University has achieved top placements in the 2026 Academic Ranking of World Universities. As in the previous year, it is one of the “Top 3” universities in Germany. In the global comparison, Ruperto Carola is in 59th position in this so-called […]
read more
Protein degradation rate helps explain why humans develop more slowly than mice
EMBL researchers have uncovered differences in protein degradation rates between humans and mice that could underlie their different developmental tempos Humans develop at a slower rate than other mammalian species, like mice, but scientists are still trying to understand the molecular basis of these differences. Now, researchers from the Ebisuya Group at EMBL Barcelona and […]
read more
A viral ‘loose cannon’ enzyme helps phages shut down bacterial defences
Scientists have found how phages, viruses that infect bacteria, orchestrate an explosion of protein modifications inside host cells that helps them evade the bacteria’s immune systems Summary As antimicrobial resistance grows around the world, novel therapies to counter it become increasingly more important. Phages – viruses that infect bacteria – are an exciting avenue of […]
read moreDonation of over 107,000 euros for sick and underprivileged children
As part of the 23rd annual global charity run, the “Roche Children’s Walk,” numerous Roche employees throughout Germany participated in a variety of running, sports, and recreational activities. At the Grenzach-Wyhlen, Mannheim, Penzberg, and Ludwigsburg sites, a total of 53,875 euros was raised. With the German Roche companies matching this amount for global aid projects, […]
read more
VectorBuilder and Lir Therapeutics Partner to Advance AAV Capsids Designed for Clinical Success
CHICAGO – August 18, 2026 – VectorBuilder, a global leader in gene delivery technologies, and Lir Therapeutics, a company pushing the boundaries of vector engineering with AI, today announced a strategic collaboration to develop adeno-associated virus (AAV) capsids designed not only for strong biological performance, but also for the manufacturability and scalability required to bring gene […]
read more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor
Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]
read more
Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026
COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]
read more
